The difference didn ' t meet the predefined statistical criteria for noninferiority. ❋ Peter Loftus (2010)
They will rely , in part, on the results of the MEDAL trial in which etoricoxib was compared with diclofenac and found to demonstrate that the cardiovascular event risk was the same with either medication using a "noninferiority study" design, which according to Graham, is "especially poor" at identifying risk between drugs. ❋ James Gaulte (2006)
And even that study has come under attack because the benefits of the Charite in the context of a noninferiority trial, were shown to be noninferior to Bagby and Kuslich cages (BAK), used in spinal fusion, a failed procedure critics say that has not been performed in years. ❋ Unknown (2006)
With these symbols comes the sense of belonging, of serene security, of smug noninferiority that suffuses all those who clothe themselves voluntarily in the golden chains of good usage. ❋ William Safire (2003)
Although the trial was structured as a noninferiority study, the efficacy advantage for cilostazol met prespecified criteria for a finding of superiority, the researchers indicated. ❋ Unknown (2010)
The primary endpoint of change in hemoglobin A1c from baseline to week 52 showed no difference between groups that exceeded the 0.4% threshold for noninferiority in the following analyses: ❋ Unknown (2010)
The antiplatelet drug cilostazol is at least as effective as aspirin - and may even surpass aspirin's efficacy - in preventing secondary stroke, according to an industry-funded, noninferiority trial in the ❋ Unknown (2010)
The second trial that has positive advance findings is EINSTEIN DVT in which monotherapy with rivaroxaban, an oral direct factor Xa inhibitor, met the primary endpoint of noninferiority to enoxaparin followed by warfarin for treatment of deep vein thrombosis. ❋ Unknown (2010)
The zotarolimus-eluting stent was also noninferior regarding the degree (±SD) of in-stent stenosis (21. 65±14.42% for zotarolimus vs. 19. 76±14.64% for everolimus, P = 0.04 for noninferiority). ❋ Serruys (2010)
The newer generation of stent met noninferiority criteria for both the primary endpoint of the composite rate of ischemia-driven target lesion revascularization and MI or cardiac death related to target vessel (difference - 0. 57%), and the secondary endpoint of quantitative coronary angiography (difference -0.03). ❋ Unknown (2010)
Glycosylated hemoglobin fell by an absolute 0.68% with the inhaled insulin combo and 0.76% with biaspart insulin in the per-protocol analysis, which passed the 0.4% margin for noninferiority, found Julio Rosenstock, MD, of the Dallas Diabetes and Endocrine Center at ❋ Unknown (2010)
Explain that a noninferiority trial of cilostazol versus aspirin found that cilostazol, a phosphodiesterase 3A inhibitor, prevented more secondary strokes and was associated with fewer hemorrhagic events. ❋ Unknown (2010)
Methods In this multicenter, noninferiority trial with minimal exclusion criteria, we randomly assigned 2292 patients to undergo treatment with coronary stents releasing either zotarolimus or everolimus. ❋ Serruys (2010)
Thus, the observed noninferiority of retail clinics says … ❋ J. R. Johnson (2010)
So doing noninferiority trials, again I think we'll see other mesalamine-based products coming forward, but it is hard for me to see how they get AB rating, and it really has stymied people in PENTASA land today. ❋ Unknown (2010)
About a quarter of the randomized active-comparator studies were billed as noninferiority trials, and the majority of these had corporate funding. ❋ Unknown (2010)
Our study also was not designed to test for noninferiority and superiority of ACASI and did not use biomarkers as some others have done. ❋ Elisabeth M. Van Der Elst Et Al. (2009)
